Scholars Central

Conference abstractPublished 20 Oct 2014

Investigation of folate receptor targeted imaging of ovarian cancer with newly 68Ga-labelled folate dimer: 68Ga-DOTA-FA2

Authors: Guoqiang Shao

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Backgroud and Aim: Ovarian cancer is the leading cause of death among women with gynecologic malignancies. The survival rate has remained low largely because of difficulties of an early diagnosis. The high-affinity folate receptor (FR) has proven a valuable target for nuclear imaging using folic acid radioconjugates because of its frequent over expression in ovarian cancer but limited expression in normal human tissues and organs. Folate monomer, commonly used for folate receptor targeted imaging, demonstrate relatively low tumor uptake and high kidney accumulatioin. We prepared 68Ga-DOTA-FA2 with the aim to optimize its biodistribution and increase tumor uptake. Methods: 68Ga-DOTA-FA2 was synthesised straightforward and its stability experiments were conducted in plasma. Cell uptake studies were performed on FR-positive SKOV3 Ovarian cancer cells. Biodistribution studies were performed in nude mice bearing SKOV3 ovarian tumors 1, 2, 4h after administration of 68Ga-DOTA-FA2 or 68Ga-DOTA-FA monomer. MicroPET-CT imaging were carried out in nude mice bearing SKOV3 ovarian tumors or FR-negative A549 lung cancer 2h after tail vein injection of 68Ga-DOTA-FA2. All animals accepted folate-free diet for 2 weeks. Results: 68Ga-DOTA-FA2 was synthesised at a specific activity of 25MBq/nmol, a radiochemical yield of more than 95%. It was stable with radioactive purity of (96.3±1.5) over 4h in plasma. SKOV3 cells uptake and internalization of 68Ga-DOTA-FA2 was FR specific. This is confirmed by the biodistribution data. In biodistribution studies tumor uptake of 68Ga-DOTA-FA2 in SKOV3 group was (11.07±1.83)%ID/g at 2h and (12.19±1.72)%ID/g at 4h. They were higher than that of 68Ga-DOTAFA (7.36±1.28)%ID/g at 2h and (9.72±2.04)%ID/g at 4h. Retention of 68Ga-DOTA-FA2 in kidneys at 4h after injection (49.3±11.02%)ID/g was lower than that of 68Ga-DOTA-FA (78.5±18.33)%ID/g. MicroPET-CT imaging demonstrated significantly higher tumor accumulation of 68Ga-DOTA-FA2 in SKOV3 ovarian tumors (10.18±1.52)%ID/g than that in A549 lung cancer (2.25±0.92)%ID/g. Conclusions: 68Ga-DOTA-FA2, with higher tumor uptake and less undesired accumulation in kidneys than FA monomer, was potential for targeted imaging of FR-positive ovarian tumors.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Cancer Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalCancer Science & Therapy
  • SubjectOncology & Cancer
  • BylineArticles whose byline prints “Guoqiang Shao”